Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in rats

被引:40
作者
de la Peña, A
Dalla Costa, T
Talton, JD
Rehak, E
Gross, J
Thyroff-Friesinger, U
Webb, AI
Müller, M
Derendorf, H
机构
[1] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
[2] UFRGS, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil
[3] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA
[4] HEXAL AG, D-83607 Holzkirchen, Germany
[5] Univ Vienna, Sch Med, Dept Clin Pharmacol, A-1090 Vienna, Austria
基金
奥地利科学基金会;
关键词
pharmacokinetics; free tissue concentrations; microdialysis; muscle; lung; rat; cefaclor; beta-lactam antibiotics;
D O I
10.1023/A:1013042128791
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To measure and compare the penetration of cefaclor from the plasma compartment into the interstitial space of lung and skeletal muscle in rats and to integrate the data in a pharmacokinetic model. Methods. Unbound interstitial concentrations in muscle and lung were measured by in vivo microdialysis following i.v. bolus doses of 50 and 75 mg/kg cefaclor. Unbound muscle concentrations were also measured after a primed, continuous i.v. infusion at an infusion rate of 0.3 mg/kg/min. Results. The cefaclor half-life in plasma, muscle and lung was approximately 1 h. Unbound cefaclor concentrations in muscle and lung were found to be virtually identical. A 2-compartment body model was fitted to the data with a tissue penetration factor (AUC(tissue(unbound))/AUC(plasma(unbound))) of approximately 0.26 independent of dose, tissue and mode of administration. Conclusions. Unbound concentrations of cefaclor in the interstitial space fluid of lung and skeletal muscle are of similar magnitude and lower than those in plasma. Using total plasma concentrations would overestimate the antibacterial activity of the drug and therefore its clinical efficacy. Instead, therapeutically active levels of cefaclor at the site of action should be taken into account. Microdialysis allows direct measurement of these unbound concentrations.
引用
收藏
页码:1310 / 1314
页数:5
相关论文
共 13 条
[1]   ISOLATION AND STRUCTURE ELUCIDATION OF A NOVEL PRODUCT OF THE ACIDIC DEGRADATION OF CEFACLOR [J].
BAERTSCHI, SW ;
DORMAN, DE ;
OCCOLOWITZ, JL ;
SPANGLE, LA ;
COLLINS, MW ;
WILDFEUER, ME ;
LORENZ, LJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (06) :622-626
[2]   Isolation and structure elucidation of the major degradation products of cefaclor formed under aqueous acidic conditions [J].
Baertschi, SW ;
Dorman, DE ;
Occolowitz, JL ;
Collins, MW ;
Spangle, LA ;
Stephenson, GA ;
Lorenz, LJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (05) :526-539
[3]   EVALUATION OF THE RELATIVE EFFICACY OF VARIOUS TECHNIQUES FOR DEPROTEINIZING PLASMA SAMPLES PRIOR TO HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS [J].
BLANCHARD, J .
JOURNAL OF CHROMATOGRAPHY, 1981, 226 (02) :455-460
[4]   Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis [J].
Dalla Costa, T ;
Nolting, A ;
Kovar, A ;
Derendorf, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) :769-778
[5]   AN APPLICATION OF MICRODIALYSIS TO DRUG TISSUE DISTRIBUTION STUDY - INVIVO EVIDENCE FOR FREE-LIGAND HYPOTHESIS AND TISSUE BINDING OF BETA-LACTAM ANTIBIOTICS IN INTERSTITIAL FLUIDS [J].
DEGUCHI, Y ;
TERASAKI, T ;
YAMADA, H ;
TSUJI, A .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1992, 15 (02) :79-89
[6]   AMOXICILLIN COMBINED WITH CLAVULANIC ACID FOR THE TREATMENT OF SOFT-TISSUE INFECTIONS IN CHILDREN [J].
FLEISHER, GR ;
WILMOTT, CM ;
CAMPOS, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :679-681
[7]   STABILITY AND BLOOD LEVEL DETERMINATIONS OF CEFACLOR, A NEW ORAL CEPHALOSPORIN ANTIBIOTIC [J].
FOGLESONG, MA ;
LAMB, JW ;
DIETZ, JV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 13 (01) :49-52
[8]  
GILLETT AP, 1979, POSTGRAD MED J, V55, P9
[9]   Impaired target site penetration of β-lactams may account for therapeutic failure in patients with septic shock [J].
Joukhadar, C ;
Frossard, M ;
Mayer, BX ;
Brunner, M ;
Klein, N ;
Siostrzonek, P ;
Eichler, HG ;
Müller, M .
CRITICAL CARE MEDICINE, 2001, 29 (02) :385-391
[10]  
KOVAR A, 1996, J PHARM SCI, V86, P52